Mechanical Deformation Promotes Secretion of IL-1α and IL-1 Receptor Antagonist

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 5084-5088

  Lee, Richard T ^a   Briggs, William H ^a   Cheng, George C ^a   Rossiter, Heidi B ^a   Libby, Peter ^a   Kupper, Thomas ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IL1RN PROTEIN, HUMAN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SIALOGLYCOPROTEIN;

ARTICLE; CELL CULTURE; CELL MEMBRANE; CELL SIZE; CYTOLOGY; DRUG ANTAGONISM; HUMAN; IMMUNOLOGY; KERATINOCYTE; MECHANICAL STRESS; PATHOLOGY; SAPHENOUS VEIN; SECRETION; VASCULAR ENDOTHELIUM;

CELL MEMBRANE; CELL SIZE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; KERATINOCYTES; RECEPTORS, INTERLEUKIN-1; SAPHENOUS VEIN; SIALOGLYCOPROTEINS; STRESS, MECHANICAL;

EID: 0031573228     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Dinarello, C. A. 1994. The interleukin-1 family: 10 years of discovery. FASEB J. 8:1314.
2. Hauser, C., J. Saurat, A. Schmidt, F. Jaunin, and J. M. Dayer. 1986. Interleukin 1 is present in normal human epidermis. J. Immunol. 136:3317.
3. Kupper, T. S. 1990. Immune and inflammatory processes in cutaneous tissues. J. Clin. Invest. 86:1783.
4. Arend, W. P. 1991. Interleukin 1 receptor antagonist: a new member of the interleukin 1 family. J. Clin. Invest. 88:1445.
5. Lennard, A. C. 1995. Interleukin-1 receptor antagonist. Crit. Rev. Immunol. 15: 77.
6. Cerretti, D. P., C. J. Kozlosky, B. Mosley, N. Nelson, K. Van Ness, T. A. Greenstreet, C. J. March, S. R. Kronheim, T. Druck, L. A. Cannizzaro, K. Huebner, and R. A. Black. 1992. Molecular cloning of the interleukin-1β converting enzyme. Science 256:97.
7. Wilson, K. P., J. F. Black, J. A. Thomson, E. E. Kim, J. P. Griffith, M. A. Navia, M. A. Murcko, S. P. Chambers, R. A. Aldape, S. A. Raybuck, and D. J. Livingston. 1994. Structure and mechanism of interleukin-1β converting enzyme. Nature 370:270.
8. Carter, D. B., M. R. Deibel, Jr., C. J. Dunn, C. S. Tomich, and A. L. Laborde, 1990. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 344:633.
9. Haskill, S., G. Martin, L. Van Le, J. Morris, A. Peace, C. F. Bigler, G. J. Jaffe, C. Hammerberg, S. A. Sporn, and S. Fong. 1991. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc. Natl. Acad Sci. USA 88:3681.
10. Muthukrishnan, L., E. Warder, and P. L. McNeil. 1991. Basic fibroblast growth factor is efficiently released from a cytosolic storage site through plasma membrane disruptions of endothelial cells. J. Cell Physiol. 148:1.
11. Yu, Q. C., and P. L. McNeil. 1992. Transient disruptions of aortic endothelial cell plasma membranes. Am. J. Pathol. 141:1349.
12. Hogquist, K. A., M. A. Nett, E. R. Unanue, and D. D. Chaplin. 1991. Interleukin 1 is processed and released during apoptosis. Proc. Natl. Acad. Sci. USA 88:8485.
13. Zhu, X., H. Komiya, A. Chirino, S. Faham, G. M. Fox, T. Arakawa, B. T. Hsu, and D. C. Rees. 1991. Three-dimensional structures of acidic and basic fibroblast growth factors. Science 251:90.
14. Gery, I., and J. L. Lepe-Zuniga. 1983. Interleukin 1: uniqueness of its production and spectrum of activities. In: Lymphokines. Vol. 9. E. Pick, ed. Academic Press, Orlando, pp. 109-126.
15. Burgess, W. H., and T. Maciag. 1989. The heparin-binding fibroblast growth factor family of proteins. Annu. Rev. Biochem. 58:575.
16. Stevenson, K. T., H. Torrano, R. M. Locksley, and D. H. Lovett. 1992. Interleukin 1: the patterns of translation and intracellular distribution support alternative secretory mechanisms. J. Cell Physiol. 152:223.
17. Wood, L. C., P. M. Elias, C. Calhoun, J. C. Tsai, C. Grunfeld, and K. R. Feingold. 1996. Barrier disruption stimulates interleukin-1α expression and release from a pre-formed pool in murine epidermis. J. Invest. Dermatol. 106:397.
18. Groves, R. W., H. Mizutani, J. D. Kieffer, and T. S. Kupper. 1995. Inflammatory skin disease in transgenic mice that express high levels of interleukin 1α in basal epidermis. Proc. Natl. Acad. Sci. USA 92:11874.
19. Schaffer, J. L., M. Rizen, G. J. L'Italien, A. Benbrahim, J. Megerman, L. C. Gerstenfeld, and M. L. Gray. 1994. Device for the application of a dynamic biaxially uniform and isotropic strain to a flexible cell culture membrane. J. Orthop. Res. 12:709.
20. Cheng, G. C., W. H. Briggs, D. S. Gerson, P. Libby, A. J. Grodzinsky, M. L. Gray, and R. T. Lee. 1997. Mechanical strain tightly controls fibroblast growth factor release from cultured human vascular smooth muscle cells. Circ. Res. 80:28.
21. Libby, P., J. M. Ordovas, K. R. Auger, A. H. Robbins, L. K. Birinyi, and C. A. Dinarello. 1986. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am. J. Pathol. 124: 179.
22. De Caterina, R., P. Libby, H. B. Peng, V. J. Thannickal, T. B. Rajavashisth, M. A. Gimbrone, Jr., W. S. Shin, and J. K. Liao. 1995. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:60.
23. McNeil, P. L., and S. Ito. 1989. Gastrointestinal cell plasma membrane wounding and resealing in vivo. Gastroenterology 96:1238.
24. Siders, W. M., J. C. Klimovitz, and S. B. Mizel. 1995. Interleukin-1 beta secretion: a possible multistep process that is regulated in a cell type-specific manner. J. Biol. Chem. 270:16258.
25. Arend, W. P., H. G. Welgus, R. C. Thompson, and S. P. Eisenberg. 1990. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J. Clin. Invest. 85:1694.
26. Gruaz-Chatellard, D., C. Baumberger, J. Saurat, and J. M. Dayer. 1991. Interleukin 1 receptor antagonist in human epidermis and cultured keratinocytes. FEBS Lett. 294:137.
27. Suttles, J., J. G. Giri, and S. B. Mizel. 1990. IL-1 secretion by macrophages. J. Immunol. 144:175.
28. Wakita, H., and M. Takigawa. 1994. E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques. Arch Dermatol. 130:457.
29. Austrup, F., D. Vestweber, E. Borges, M. Lohning, R. Brauer, U. Herz, H. Renz, R. Hallmann, A. Scheffold, A. Radbruch, and A. Hamann. 1997. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 385:81.
30. Alon, R., H. Rossiter, X. Wang, T. A. Springer, and T. S. Kupper. 1994. Distinct cell surface ligands mediate T lymphocyte attachment and rolling on P and E selectin under physiological flow. J. Cell Biol. 127:1485.
31. Rossiter, H., F. van Reijsen, G. C. Mudde, F. Kalthoff, C. A. F. M. Bruijnzeel-Koomen, L. J. Picker, and T. S. Kupper. 1994. Skin disease-related T cells bind to endothelial selectins: expression of cutaneous lymphocyte antigen (CLA) predicts E-selectin but not P-selectin binding. Eur. J. Immunol. 24:205.
32. Picker, L. J., T. K. Kishimoto, C. W. Smith, R. A. Warnock, and E. C. Butcher. 1991. ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 349:796.